Company / Current Assets
Traws Pharma, Inc. Current Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$8.0M
FY2024
5-year range
$8.0M / $55.4M
FY2020-FY2024
Trend
-64.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 3 consecutive years, from $55M in FY2021 to $8M in FY2024.
Based on SEC 10-K filings.
$8M in FY2024 with a 5-year CAGR of -19.4%.
Declined from $39M to $8M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -47.6%
- 5-Year CAGR
- -19.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Traws Pharma, Inc.'s current assets has declined for 3 consecutive years.
- 5-year CAGR of -19.4%, indicating a declining trend.
- In FY2024, current assets decreased 64.8% year-over-year.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $8.0M | -64.8% |
| FY2023 | $22.7M | -42.4% |
| FY2022 | $39.3M | -29.0% |
| FY2021 | $55.4M | +180.2% |
| FY2020 | $19.8M | -15.7% |
| FY2019 | $23.5M | +32.1% |
| FY2018 | $17.8M | +262.3% |
| FY2017 | $4.9M | -78.7% |
| FY2016 | $23.1M | -0.5% |
| FY2015 | $23.2M | -50.6% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026